Editorial: Molecular mechanisms in lethal states of prostate cancer

被引：0
|
作者：
Kim, Daniel M. [1 ]
Lyou, Yung [2 ]
Ellis, Leigh [3 ,4 ]
Posadas, Edwin [1 ]
Bhowmick, Neil [1 ]
Gong, Jun [1 ]
机构：
[1] Samuel Oschin Comprehens Canc Inst, Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Providence St Jude Med Ctr, Dept Oncol, Fullerton, CA USA
[3] Uniformed Serv Univ Hlth Sci, Henry M Jackson Fdn Advancement Mil Med Inc, Ctr Prostate Dis Res, Murtha Canc Ctr Res Program,Dept Surg, Bethesda, MD USA
[4] Henry M Jackson Fdn Advancement Mil Med Inc, Walter Reed Natl Mil Med Ctr, Bethesda, MD USA
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
castration-resistant prostate cancer (CRPC); castration-sensitive prostate cancer; microRNA; androgen signaling pathway; bony metastasis; novel hormonal therapy; ANDROGEN-RECEPTOR;
D O I：
10.3389/fonc.2024.1475178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Molecular mechanisms involving prostate cancer racial disparity
    Hatcher, David
    Daniels, Garrett
    Osman, Iman
    Lee, Peng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2009, 1 (03): : 235 - 248
  • [32] Lymphangiogenesis in prostate cancer: New insights into molecular mechanisms
    Tilki, Derya
    Oliveira-Ferrer, Leticia
    Singer, Bernhard B.
    Stief, Christian G.
    Ergun, Suleyman
    JOURNAL OF UROLOGY, 2008, 179 (04): : 105 - 105
  • [33] Molecular mechanisms underlying the development of neuroendocrine prostate cancer
    Liu, Shiqin
    Alabi, Busola Ruth
    Yin, Qingqing
    Stoyanova, Tanya
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 57 - 68
  • [34] Prostate cancer and bone: clinical presentation and molecular mechanisms
    Wells, Kristina, V
    Krackeler, Margaret L.
    Jathal, Maitreyee K.
    Parikh, Mamta
    Ghosh, Paramita M.
    Leach, J. Kent
    Genetos, Damian C.
    ENDOCRINE-RELATED CANCER, 2023, 30 (09)
  • [35] Molecular mechanisms and clinical applications of exosomes in prostate cancer
    Cui, Xiaolin
    Fu, Qiang
    Wang, Xueying
    Xia, Pengcheng
    Cui, Xianglun
    Bai, Xiaohui
    Lu, Zhiming
    BIOMARKER RESEARCH, 2022, 10 (01)
  • [36] Molecular genetic mechanisms of drug resistance in prostate cancer
    G. S. Krasnov
    A. A. Dmitriev
    A. F. Sadritdinova
    N. N. Volchenko
    E. N. Slavnova
    T. V. Danilova
    A. V. Snezhkina
    N. V. Melnikova
    M. S. Fedorova
    V. A. Lakunina
    A. A. Belova
    K. M. Nyushko
    B. Y. Alekseev
    A. D. Kaprin
    A. V. Kudryavtseva
    Molecular Biology, 2015, 49 : 638 - 648
  • [37] Function and molecular mechanisms of neuroendocrine cells in prostate cancer
    Huang, Jiaoti
    Wu, Chengyu
    Di SantAgnese, P. Anthony
    Yao, Jorge L.
    Na, Yanqun
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2007, 29 (03): : 128 - 138
  • [38] Molecular mechanisms involved in hormone resistance of prostate cancer
    Cabrespine, A
    Guy, L
    Chollet, P
    Debiton, É
    Bay, JO
    BULLETIN DU CANCER, 2004, 91 (10) : 747 - 757
  • [39] Antidiabetic drugs influence molecular mechanisms in prostate cancer
    Heidegger, I.
    Zieher, M.
    Eigentler, A.
    Schaefer, G.
    Pichler, R.
    Puhr, M.
    Horninger, W.
    Klocker, H.
    Pircher, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 322 - 323
  • [40] Molecular genetic mechanisms of drug resistance in prostate cancer
    Krasnov, G. S.
    Dmitriev, A. A.
    Sadritdinova, A. F.
    Volchenko, N. N.
    Slavnova, E. N.
    Danilova, T. V.
    Snezhkina, A. V.
    Melnikova, N. V.
    Fedorova, M. S.
    Lakunina, V. A.
    Belova, A. A.
    Nyushko, K. M.
    Alekseev, B. Y.
    Kaprin, A. D.
    Kudryavtseva, A. V.
    MOLECULAR BIOLOGY, 2015, 49 (05) : 638 - 648
12345